Somatostatin Receptor Study with 111-Indium Octreotide
Indication
Scanning of intrahepatic and extrahepatic neuroendocrine tumors.
Procedure
Whole Body and SPECT scans 4 hrs and 24 hrs post IV administration.
Attention
Due to the very high price of the Octreotide it is not covered by Medicare. It requires referral of patients through the public hospital system.
Mr BT,56 yo with known carcinoid. Extent of the disease ?. 24 h Octreoscan presents multiple lesions in the liver and no extrahepatic lesions. Physiological uptake in spleen and kidneys.